Foetal supraventricular tachycardia treated with sotalol
Identifieur interne : 002104 ( Istex/Corpus ); précédent : 002103; suivant : 002105Foetal supraventricular tachycardia treated with sotalol
Auteurs : S-E Sonesson ; J-C Fouron ; E. Wesslen-Eriksson ; E. Jaeggi ; P. WinbergSource :
- Acta Pædiatrica [ 0803-5253 ] ; 1998-05.
English descriptors
- KwdEn :
Abstract
Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253 This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.
Url:
DOI: 10.1111/j.1651-2227.1998.tb01508.x
Links to Exploration step
ISTEX:BFFCE4D7E53714C249AD0C05E6097550913AF91FLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Foetal supraventricular tachycardia treated with sotalol</title><author><name sortKey="Sonesson, S" sort="Sonesson, S" uniqKey="Sonesson S" first="S-E" last="Sonesson">S-E Sonesson</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Fouron, J" sort="Fouron, J" uniqKey="Fouron J" first="J-C" last="Fouron">J-C Fouron</name><affiliation><mods:affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</mods:affiliation></affiliation></author><author><name sortKey="Wesslen Riksson, E" sort="Wesslen Riksson, E" uniqKey="Wesslen Riksson E" first="E" last="Wesslen-Eriksson">E. Wesslen-Eriksson</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Jaeggi, E" sort="Jaeggi, E" uniqKey="Jaeggi E" first="E" last="Jaeggi">E. Jaeggi</name><affiliation><mods:affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</mods:affiliation></affiliation></author><author><name sortKey="Winberg, P" sort="Winberg, P" uniqKey="Winberg P" first="P" last="Winberg">P. Winberg</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BFFCE4D7E53714C249AD0C05E6097550913AF91F</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1111/j.1651-2227.1998.tb01508.x</idno><idno type="url">https://api-v5.istex.fr/document/BFFCE4D7E53714C249AD0C05E6097550913AF91F/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002104</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002104</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Foetal supraventricular tachycardia treated with sotalol</title><author><name sortKey="Sonesson, S" sort="Sonesson, S" uniqKey="Sonesson S" first="S-E" last="Sonesson">S-E Sonesson</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Fouron, J" sort="Fouron, J" uniqKey="Fouron J" first="J-C" last="Fouron">J-C Fouron</name><affiliation><mods:affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</mods:affiliation></affiliation></author><author><name sortKey="Wesslen Riksson, E" sort="Wesslen Riksson, E" uniqKey="Wesslen Riksson E" first="E" last="Wesslen-Eriksson">E. Wesslen-Eriksson</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Jaeggi, E" sort="Jaeggi, E" uniqKey="Jaeggi E" first="E" last="Jaeggi">E. Jaeggi</name><affiliation><mods:affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</mods:affiliation></affiliation></author><author><name sortKey="Winberg, P" sort="Winberg, P" uniqKey="Winberg P" first="P" last="Winberg">P. Winberg</name><affiliation><mods:affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Pædiatrica</title><idno type="ISSN">0803-5253</idno><idno type="eISSN">1651-2227</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1998-05">1998-05</date><biblScope unit="volume">87</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="584">584</biblScope><biblScope unit="page" to="587">587</biblScope></imprint><idno type="ISSN">0803-5253</idno></series><idno type="istex">BFFCE4D7E53714C249AD0C05E6097550913AF91F</idno><idno type="DOI">10.1111/j.1651-2227.1998.tb01508.x</idno><idno type="ArticleID">APA584</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0803-5253</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Foetal</term><term>sotalol</term><term>supraventricular tachycardia</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253 This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>S‐E Sonesson</name><affiliations><json:string>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</json:string></affiliations></json:item><json:item><name>J‐C Fouron</name><affiliations><json:string>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</json:string></affiliations></json:item><json:item><name>E Wesslen‐Eriksson</name><affiliations><json:string>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</json:string></affiliations></json:item><json:item><name>E Jaeggi</name><affiliations><json:string>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</json:string></affiliations></json:item><json:item><name>P Winberg</name><affiliations><json:string>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Foetal</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>sotalol</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>supraventricular tachycardia</value></json:item></subject><articleId><json:string>APA584</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253 This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.</abstract><qualityIndicators><score>4.694</score><pdfVersion>1.2</pdfVersion><pdfPageSize>596 x 842 pts (A4)</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>1342</abstractCharCount><pdfWordCount>2294</pdfWordCount><pdfCharCount>14844</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>200</abstractWordCount></qualityIndicators><title>Foetal supraventricular tachycardia treated with sotalol</title><genre><json:string>article</json:string></genre><host><title>Acta Pædiatrica</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1651-2227</json:string></doi><issn><json:string>0803-5253</json:string></issn><eissn><json:string>1651-2227</json:string></eissn><publisherId><json:string>APA</json:string></publisherId><volume>87</volume><issue>5</issue><pages><first>584</first><last>587</last><total>4</total></pages><genre><json:string>journal</json:string></genre></host><categories><wos><json:string>science</json:string><json:string>pediatrics</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>clinical medicine</json:string><json:string>pediatrics</json:string></scienceMetrix><inist><json:string>sciences appliquees, technologies et medecines</json:string><json:string>sciences biologiques et medicales</json:string><json:string>sciences medicales</json:string></inist></categories><publicationDate>1998</publicationDate><copyrightDate>1998</copyrightDate><doi><json:string>10.1111/j.1651-2227.1998.tb01508.x</json:string></doi><id>BFFCE4D7E53714C249AD0C05E6097550913AF91F</id><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api-v5.istex.fr/document/BFFCE4D7E53714C249AD0C05E6097550913AF91F/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api-v5.istex.fr/document/BFFCE4D7E53714C249AD0C05E6097550913AF91F/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api-v5.istex.fr/document/BFFCE4D7E53714C249AD0C05E6097550913AF91F/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Foetal supraventricular tachycardia treated with sotalol</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>1998</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Foetal supraventricular tachycardia treated with sotalol</title><author xml:id="author-1"><persName><forename type="first">S‐E</forename><surname>Sonesson</surname></persName><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation></author><author xml:id="author-2"><persName><forename type="first">J‐C</forename><surname>Fouron</surname></persName><affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</affiliation></author><author xml:id="author-3"><persName><forename type="first">E</forename><surname>Wesslen‐Eriksson</surname></persName><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation></author><author xml:id="author-4"><persName><forename type="first">E</forename><surname>Jaeggi</surname></persName><affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</affiliation></author><author xml:id="author-5"><persName><forename type="first">P</forename><surname>Winberg</surname></persName><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation></author></analytic><monogr><title level="j">Acta Pædiatrica</title><idno type="pISSN">0803-5253</idno><idno type="eISSN">1651-2227</idno><idno type="DOI">10.1111/(ISSN)1651-2227</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1998-05"></date><biblScope unit="volume">87</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="584">584</biblScope><biblScope unit="page" to="587">587</biblScope></imprint></monogr><idno type="istex">BFFCE4D7E53714C249AD0C05E6097550913AF91F</idno><idno type="DOI">10.1111/j.1651-2227.1998.tb01508.x</idno><idno type="ArticleID">APA584</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1998</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253 This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>Foetal</term></item><item><term>sotalol</term></item><item><term>supraventricular tachycardia</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1998-05">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api-v5.istex.fr/document/BFFCE4D7E53714C249AD0C05E6097550913AF91F/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1651-2227</doi><issn type="print">0803-5253</issn><issn type="electronic">1651-2227</issn><idGroup><id type="product" value="APA"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ACTA PAEDIATRICA">Acta Pædiatrica</title></titleGroup></publicationMeta><publicationMeta level="part" position="05005"><doi origin="wiley">10.1111/apa.1998.87.issue-5</doi><numberingGroup><numbering type="journalVolume" number="87">87</numbering><numbering type="journalIssue" number="5">5</numbering></numberingGroup><coverDate startDate="1998-05">May 1998</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="0058400" status="forIssue"><doi origin="wiley">10.1111/j.1651-2227.1998.tb01508.x</doi><idGroup><id type="unit" value="APA584"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><eventGroup><event type="firstOnline" date="2007-01-02"></event><event type="publishedOnlineFinalForm" date="2007-01-02"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-15"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="584">584</numbering><numbering type="pageLast" number="587">587</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:APA.APA584.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received Oct. 7, 1997. Accepted in revised form Jan. 28, 1998</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="18"></count><count type="linksCrossRef" number="6"></count></countGroup><titleGroup><title type="main">Foetal supraventricular tachycardia treated with sotalol</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>S‐E</givenNames><familyName>Sonesson</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>J‐C</givenNames><familyName>Fouron</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>E</givenNames><familyName>Wesslen‐Eriksson</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a2"><personName><givenNames>E</givenNames><familyName>Jaeggi</familyName></personName></creator><creator creatorRole="author" xml:id="cr5" affiliationRef="#a1"><personName><givenNames>P</givenNames><familyName>Winberg</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1"><unparsedAffiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="CA"><unparsedAffiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">Foetal</keyword><keyword xml:id="k2">sotalol</keyword><keyword xml:id="k3">supraventricular tachycardia</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253</p><p>This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="c1">S‐E Sonesson, Department of Paediatric Cardiology, Astrid Lindgren's Children's Hospital, S‐17176 Stockholm, Sweden</note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Foetal supraventricular tachycardia treated with sotalol</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Foetal supraventricular tachycardia treated with sotalol</title></titleInfo><name type="personal"><namePart type="given">S‐E</namePart><namePart type="family">Sonesson</namePart><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J‐C</namePart><namePart type="family">Fouron</namePart><affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Wesslen‐Eriksson</namePart><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E</namePart><namePart type="family">Jaeggi</namePart><affiliation>Foetal Cardiology Unit, Division of Paediatric Cardiology, Department of Paediatrics, St Justine Hospital, University of Montreal, Montreal, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P</namePart><namePart type="family">Winberg</namePart><affiliation>Paediatric Cardiology Unit, Department of Woman and Child Health, St Göran's Children's Hospital, Karolinska Institute, Stockholm, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1998-05</dateIssued><edition>Received Oct. 7, 1997. Accepted in revised form Jan. 28, 1998</edition><copyrightDate encoding="w3cdtf">1998</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">18</extent></physicalDescription><abstract lang="en">Sonesson S‐E, Fouron J‐C, Wesslen‐Eriksson E, Jaeggi E, Winberg P. Foetal supraventricular tachycardia treated with sotalol. Acta Pædiatr 1998; 87: 584‐7. Stockholm. ISSN 0803‐5253 This retrospective study (1991‐95) presents our experience with sotalol in the treatment of 14 foetuses with supraventricular tachycardia (SVT). SVT was diagnosed in a structurally normal heart at a gestational age of 24‐35 (median 28) weeks. In eight foetuses, hydrops was evident at presentation. In all patients pharmacological conversion with digoxin was tried before sotalol treatment was started. Sotalol was given orally to the mothers in a dose of 80–160 mg x2. Cardioversion was obtained in 10 foetuses. In seven of these patients re‐entry tachycardia and in five pre‐excitation could be documented after birth. In two foetuses not responding to sotalol a long RP tachycardia was demonstrated; even when using digoxin, sotalol, flecainide and/or propafenone in different combinations after birth complete suppression of the arrhythmia was not obtained. Two severely hydropic foetuses died 1 and 10 d, respectively, after starting with sotalol. The 12 surviving infants were doing well except for one infant, with a cerebral lesion probably related to the arrhythmia. These findings demonstrate that sotalol can be useful in the treatment of foetal SVT.</abstract><subject lang="en"><genre>keywords</genre><topic>Foetal</topic><topic>sotalol</topic><topic>supraventricular tachycardia</topic></subject><relatedItem type="host"><titleInfo><title>Acta Pædiatrica</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0803-5253</identifier><identifier type="eISSN">1651-2227</identifier><identifier type="DOI">10.1111/(ISSN)1651-2227</identifier><identifier type="PublisherID">APA</identifier><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>584</start><end>587</end><total>4</total></extent></part></relatedItem><identifier type="istex">BFFCE4D7E53714C249AD0C05E6097550913AF91F</identifier><identifier type="DOI">10.1111/j.1651-2227.1998.tb01508.x</identifier><identifier type="ArticleID">APA584</identifier><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002104 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002104 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:BFFCE4D7E53714C249AD0C05E6097550913AF91F
|texte= Foetal supraventricular tachycardia treated with sotalol
}}
| This area was generated with Dilib version V0.6.29. |  |